Abscopal Effect of Radiotherapy in Imatinib-resistant Dermatofibrosarcoma Protuberans
Open Access
- 8 January 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (1) , e3857
Abstract
Local tumor control and symptom relief have been the major advantage of radiotherapy in clinical practice. In the past years, the systemic anti-tumor effect of radiotherapy, also known as the abscopal effect, has been reported with limited studies. With the advent of immunotherapy, the frequency of the abscopal effect has increased in patients who receive sequential treatment with radiotherapy and immunotherapy or patients who receive radiotherapy after acquiring resistance to immunotherapy. A novel cancer treatment modality, such as molecular targeted therapy, has been associated with the immune response within the tumor but its systemic anti-tumor effect, when combined with radiotherapy, is yet to be documented. There have been few studies to date assessing the immunological effects of imatinib on tumors; however, the mechanism of tumor regression or resistance acquisition is poorly understood. We present a 56-year-old male diagnosed with dermatofibrosarcoma protuberans (DFSP) who developed resistance to imatinib after five months of treatment. Following subsequent local radiotherapy to the primary tumor, he had complete clinical remission of the primary and metastatic lesions.Keywords
This publication has 21 references indexed in Scilit:
- Years in CologneAnnual Review of Immunology, 2013
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of IdoNature Medicine, 2011
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Costimulatory and coinhibitory receptors in anti‐tumor immunityImmunological Reviews, 2009
- Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing PatientsCancer Research, 2009
- Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate CancerClinical Cancer Research, 2005
- Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberansInternational Journal of Cancer, 2002
- Defective death receptor signaling as a cause of tumor immune escapeSeminars in Cancer Biology, 2002
- Immunosuppression associated with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1977
- Whole Body Irradiation—Radiobiology or Medicine?British Journal of Radiology, 1953